Enterprise of the Year for 2021
Dr. Bata Ltd. has been awarded the title "Enterprise of the Year" for 2021, for its innovation and commercial performance in recent years.
Dr. Bata Ltd. has been awarded the title "Enterprise of the Year" for 2021, for its innovation and commercial performance in recent years.
Dr. Bata Ltd, is making remarkable strides in its journey towards sustainable production. As part of a comprehensive five-year action plan that commenced in 2020, the company has recently undertaken a series of modernization initiatives to optimize its manufacturing processes. By embracing automation and implementing advanced technologies, the company has taken a giant leap towards reducing its carbon footprint and becoming more environmentally friendly. These strategic investments are poised to revolutionize the way Dr. Bata operates, benefiting both the company and the planet.
Cremona International Livestock Exhibition was held in Cremona, Italy at the end of October.
As a biotechnological company the research and development was always the most important part of the life of Dr Bata Ltd. The scientific research of today will be the basis of the new commercial products of the future. This is the reason that Dr Bata Ltd is committed to the continuous development of R&D.
Disantic is a herbal additive containing herbs that have bactericidal and immunostimulant effects. We have tested it with 200 animals.
Dr. Bata Ltd. regularly supports its owners alma mater (University of Technology and Economics) sport activity, the racers preparation and participation on international rowing races of the Technical University Rowing Club.
In the framework of the Central Hungarian Operational Program (Közép-Magyarországi Operatív Program), Dr. BATA Hungarian Canadian Biotechnology Research Development Ltd. was awarded 97 500 000 HUF of subsidies from EU and domestic central budget sources to develop environmentally friendly, food- safety-precision trace element of premixes for the commercial livestock.
The project’s total budget is 150 million HUF.
Our company completed the project KMOP-1.1.1-07/1-2008-0013 on the 31st May 2011.
The Dr. Bata Ltd. won 318.66 million HUF non-refundable funding on the project “Funding for market-oriented research and development”. The investment budget of 480.33 million HUF helped to develop a complex, biotechnology based, acid-resistant, protected NSP enzymproduct development of probiotic effect. Throughout this project the solution was found for the economical and environment friendly treatment and utilization of biological, rich in fiber by-products.
In the framework of the Central Hungarian Operational Program, the Dr BATA Hungarian Canadian Biotechnology Research Development Ltd. was awarded 115 million HUF in support of the project "Support for Enterprise Innovation". In the framework of the project, we applied for the development of a herbal combination-based product family against digestive diseases in pigs and help for the market access of the developed product. The total budget of the project was 255.56 million HUF.
Natural herb countaining feed additive for swine
Feed additive against the negative effects of mycotoxins for swine
Natural phytobiotic combination for poultry
A polysaccharidose enzyme containing feed supplement for ruminants
A probiotic innovation for the optimal microbiom
A natural phytobiotic, prebiotic combination for maintaining gut balance
Bioavailable minerals